Highlights and Quick Summary
- Current Revenue (Deferred) for the quarter ending September 30, 2023 was $345 Thousand (a -31.0% decrease compared to previous quarter)
- Year-over-year quarterly Current Revenue (Deferred) decreased by -22.47%
- Annual Current Revenue (Deferred) for 2022 was $445 Thousand (a -67.11% decrease from previous year)
- Annual Current Revenue (Deferred) for 2021 was $1.35 Million (a -48.56% decrease from previous year)
- Annual Current Revenue (Deferred) for 2020 was $2.63 Million (a 237.18% increase from previous year)
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Current Revenue (Deferred) of Absci Corporation
Most recent Current Revenue (Deferred)of ABSI including historical data for past 10 years.Interactive Chart of Current Revenue (Deferred) of Absci Corporation
Absci Corporation Current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.35 | $0.5 | $0.36 | – | – |
| 2022 | $0.45 | $0.68 | $2.8 | $2.79 | $0.45 |
| 2021 | $1.35 | $1.97 | $1.78 | $2.4 | $1.35 |
| 2020 | – | – | – | $2.63 | $2.63 |
| 2019 | – | – | – | – | $0.78 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology